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Abstract
Background: In a period when a public-private mix in Greece is under consideration and hospital
budgets become restrained, economic assessment is important for rational decision making. The
study aimed to estimate the hospitalization cost of neonates admitted to the ICUs and demonstrate
discrepancies with reimbursement.
Methods: Chosen methodology was based on the selection of medical records of all NICUs and
intermediate care admissions within February to April 2004. Neonates (n = 99) were classified
according to birthweight and gestational age.
Results: Mean cost per infant was estimated at €5.485 while reimbursement from social funds
arises to €3.952. Costs per birthweight or gestational age show an inverse relationship. Personnel
costs accounted for 59.9%, followed by enteral/parenteral feeding (16.14%) and pharmaceuticals
expenses (11.10%) of all resources consumed. Sensitivity analysis increases the robustness of the
results
Conclusion: Neonatal intensive care in Greece is associated with significant costs that exceed
reimbursement from social funds. Reimbursement should be adjusted to make neonatal intensive
care economically viable to private hospitals and thus, increase capacity of the services provided.
Background
The National Health System (ESY) in Greece was estab-
lished in 1983 providing free access to all public services
at the point of use. Given that the private sector had lim-
ited space for growth, it embarked on providing services in
order to increase market share by setting up diagnostic
centres and investing in expensive medical technology. As
such, the Greek health care sector was converted in a
mixed public-private system [1]. In 2004, the total health-
care expenditure in the country was 7.9% of the GDP of
which 52.8% comes from the public sector while the
remaining from the private sector [2].
Intensive care cost is one of the largest components of
inpatient care worldwide ranging from 15% to 35% of
hospital budgets and accounting for about 0.2% to 1.5%
of gross domestic product (GDP) [3-7]. Neonatal inten-
sive care for low birth weight infants is ranked among the
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most costly hospital admissions and is regarded as one of
the most expensive components of pediatric health care
accounting for about 10% of total pediatric expenses
[7,8].
Utilization of NICUs has generated a great deal of concern
in several countries due to their continuing increasing
demand and resource consumption. Fast technological
innovations and improved obstetric practices, in combi-
nation with the highly specialized personnel and the
intense working conditions, are in large part responsible
for the remarkable decline in neonatal and perinatal mor-
tality rates and the aforementioned high share costs. In
the international literature, intensive care has been proved
cost-effective since the benefits for saving children's lives
are far greater than the relative costs [3,8-11]. Hence, in an
era of increased financial scrutiny and competing
demands for limited healthcare resources, technology
assessment constitutes a useful managerial tool since it
enables decision-makers or health professionals to make
more rational and cost-conscious clinical decisions.
In Greece, during the last decades there has been a signif-
icant reduction in neonatal (50%) and perinatal (64%)
mortality rates reaching at 8‰ and 4‰ respectively.
However, an increasing rate in the preterm birth and low
birth weight newborns has been observed [12-14]. In
addition, the continuing urbanization and depopulation
of rural areas, gave a shift in the health services demand to
the urban areas resulting to large socio-economic and geo-
graphical inequalities in the health services' provision
[6,15,16]. In Greece there is an inadequate supply and
unequal distribution of the NICUs beds in the various
geographical regions. As presented in Table 1, the large
urban areas (Athens and Thessaloniki) have the highest
share of births as well as the majority of NICUs beds since
they cover the majority of NICUs admissions and conse-
quently, the lowest ratio of births per NICU beds.
Having identified the insufficient coverage of ICU beds of
the public sector, the NHS introduced a public-private
contract services system, which could allow reimburse-
ment of the provision of intensive care for patients admit-
ted to private hospitals so as to meet population needs.
The creation of a public-private mix in the provision of
intensive care faces great difficulties in Greece. The vast
differentiation between NHS and private sector prices pre-
vents social insurance funds to reimburse the provision of
health care of their insured population in the private sec-
tor. The maintenance of a per diem hospital reimburse-
ment system by the insurance funds results in deficits of
the hospital budgets and prevents the private health pro-
viders to accept any public-private mix arrangements [7].
In addition, the lack of hospital costs assessments either
for diagnostic related groups or surgical operations, as
well as the overall insufficiency of national costing data,
assigned priority to the cost analysis of the intensive care
units.
Given the experience outlined above, the objective of the
study is the cost analysis of resource consumption and the
cost estimation for neonates admitted to NICUs in
Greece, either per birth weight or per gestational age clas-
sification. The identification of cost per infant can facili-
tate public-private contracts to expand access to neonatal
intensive care, once the significant underpayment by the
social fund is taken into consideration.
Methods
"Alexandra" and "Helena Venizelou" were the selected
hospitals of the study. The selection of the specific hospi-
tals was based on the fact that they are acknowledged as
the two leading public obstetric and maternity hospitals
of Athens representing almost 45% of the total number of
deliveries that took place in Athens, in 2004.
Both hospitals have been incorporated into the National
Health System (ESY) since 1986, cover 80% of the NICUs
admissions of the public obstetric hospitals of Athens and
40% of the total NICU admissions in the public and pri-
vate obstetric hospitals in the Athens area.
The District Maternity Hospital "Helena Venizelou" pro-
vides tertiary healthcare services with 7,000 deliveries
approximately per year and one NICU with 20 mechani-
cal ventilators. It also has a capacity of 384 beds, a prena-
tal control unit, along with a milk Bank and a Maternal
Breast-feeding department. The second University Mater-
Table 1: Distribution of NICU beds in public hospitals in Greece
Geographical regions Number 
of Births
Beds 
(NICUs) *
Births per 
NICU beds
Greater Athens (Attiki) 14,851 85 175
Thessaloniki 6,660 30 222
Macedonia & Thrace 4,064 5 813
Western Macedonia 1,380 - -
Western Greece 3,664 10 366
Ipiros 2,523 6 421
Ionian Islands 1,033 - -
Peloponnesus 2,632 - -
Crete 3,919 15 261
Aegean Islands 2,787 - -
Thessaly 3,022 8 378
Central Greece & Evia 1,903 - -
Total 48,438 159 305
Source: National Statistics Service of Greece, 2004
*The number of beds was given on request by the administration of 
the hospitals; the only official national reporting is the number of 
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nity Hospital "Alexandra" is one of the largest specialist
hospitals in Athens, with a capacity of 300 beds, one
NICU with 12 mechanical ventilators and 6,500 deliveries
per year. According to patient records, although both hos-
pitals are in the center of Athens, they host deliveries from
Central Greece, Evia, the islands and neighboring counties
of the Peloponnesus region.
Data was prospectively collected for all NICU and inter-
mediate care admissions of both hospitals within a three
month period (February to April 2004). The sample
included neonates who had been admitted to both ICUs
as premature, low birth weight and those who needed
intensive care support for various reasons. Both hospitals
examined are maternity hospitals and do not undertake
surgeries or any type of operations. In cases of acute events
that require the latter, neonates are transferred in paediat-
ric hospitals.
Once the data was collected, infants were categorized into
groups according to their birthweight (gr <1000, 1001–
1500 gr, 1501–2000 gr, 2001–2500 gr and 2501 < gr) and
to their gestational age (wk < 24, 24 ≤ wk < 28, 28 ≤ wk <
32, 32 ≤ wk) [18,19]. Neonates that did not survive
formed a separate group (deaths) in the analysis to avoid
potential underestimation of the cost per infant.
The estimation of cost was performed using a "bottom up
approach", which identifies all the resources directly
employed for an intervention. It is commonly used when
considering technologies with a large component of staff
input or overheads where healthcare systems do not allo-
cate costs to the intervention level, such as the intensive
care unit [20]. In these circumstances and since no
national data were available this microeconomic
approach was chosen to increase consistency and trans-
parency of our results. Cost was based on the analytical
recording of a) the resource consumption of supplies,
medication, laboratory and medical tests and enteral and
parenteral feeding on an everyday basis per infant, b) the
infrastructure and various overhead costs such as electric-
ity, cleaning, telephone, watering, heating, maintenance
and repairs and c) personnel cost.
Public sector prices and NHS perspective have been used
in the analysis. Depreciation of the capital assets was not
included due to lack of data. For that reason, the analysis
focused only on variable costs [21].
All personnel cost data were obtained from budgetary
control statements provided by both hospitals' finance
departments. Personnel cost includes the wages of the
medical and nursing staff that was fully employed in the
NICU and the intermediate section II of the two hospitals.
It also includes the cost of paramedical, administrative
and other personnel that were calculated based on the
number of patients admitted for each hospital.
The cost of enteral and parenteral feeding was estimated
based on the substances used for each infant. Cost of con-
sumables was also reported on a per infant basis and was
obtained by each hospital supplies department '[See Addi-
tional file 1]'. Infrastructure and general overhead costs
such as electricity, water, heating, telephone and other
utilities, were allocated based on the area occupied
(square meters) by the NICU and the intermediate section
II unit over the total area of the hospital. The cost of diag-
nostic tests, drug utilization and any other medical exams
was reported on a per-case basis '[see Additional file 2]'.
The estimated cost was compared with the reimbursement
from the social security funds based on the per diem pay-
ment (Government Gazette 99B/10-2-98). The amount
reimbursed per inpatient day for the intensive care unit is
at €187, while for the intermediate section II reaches €93.
From the data collected a descriptive statistical analysis
was conducted. Mean ± standard deviation values are
given when necessary and 95% confidence intervals are
estimated. Sensitivity analysis was undertaken to explore
the reliability of our estimates. The monetary values used
in the paper have been converted in US Dollars in 2004
using an inflation rate of 3% for all studies to allow inter-
national comparisons. The conversion rates used depend-
ing on the study were:
January 1998: 1 US$: 0.61 GBP
January 2004: 1 US$: 0.79€
Results
The study sample consisted of 99 neonates corresponding
to approximately 45% of overall NICU admissions annu-
ally, 44 were from "Helena Venizelou" hospital and 55
from "Alexandra" hospital Table 2 presents the character-
istics of the sample from both hospitals and the classifica-
tion by birth weight and gestational age separately.
Table 3 provides information on the cost drivers of the
ancillary services, including pharmaceutical, laboratory,
consumables and enteral/parenteral feeding costs. Phar-
maceutical costs include the costs of any drug used during
infants' overall stay in the hospital. During the study
period, approximately 70 pharmaceutical products were
used in the aforementioned NICUs and intermediate sec-
tions II of both hospitals. These included antibiotics, sur-
factants and others. Laboratorial costs included tests such
as CBC, blood gas analysis, ultrasounds, MRIs and other.Cost Effectiveness and Resource Allocation 2007, 5:9 http://www.resource-allocation.com/content/5/1/9
Page 4 of 7
(page number not for citation purposes)
Table 4 presents analytical costs for infants' hospitalisa-
tion in NICUs in Athens. Mean cost per infant classified
by birth weight and gestational age is presented. It is esti-
mated at €5.845 [95% CI: 5.404, 6285] in 2004 with
mean length of stay (LOS) of 27.5 days. It is observed that
cost per infant is inversely related to both birth weight and
gestational age which is compatible to the literature
[9,13,14,19,22,23]. Also, the underpayment by social
security funds becomes evident, except in the small for
gestational age and very low birth weight infants were it is
fully covered.
According to the cost breakdown presented in Table 5, the
highest share of resources was allocated in personnel
wages (59.9%), in enteral/parenteral feeding (16.1%) and
pharmaceuticals (11%).
Sensitivity analysis
From the data presented in table 4, one can observe that
length of stay (LOS) is highly skewed. Therefore, a sensi-
tivity analysis was run to correct for the non-normality of
the distribution by excluding outliers (n = 10); all came
from the lowest gestational and/or birthweight clasifica-
tion (Table 6). The difference in mean cost per infant
between the two scenarios shows statistical significance
between the groups (p = 0,018). However, in everyday
clinical practice neonatal intensive care unit admits
extremely low birth weight infants accounting for 5–8%
of the overall premature infants [18]. Thus, it was
assumed appropriate not to treat them as outliers and
exlude them from the analysis.
Table 3: Total ancillary services cost by weight and gestational age in Athens in 2004 Euros (rounded to the closest integer)
Infants 
Classification
N Pharmaceutical 
Cost (€)
Laboratory Cost 
(€)
Consumables 
Cost (€)
Enteral/Parenteral 
Feeding (€)
Total Ancillary 
Cost (€)
Weight
< 1000 gr 9 24,222 5,431 3,566 11,980 45,199
1001 – 1500 gr 18 24,361 14,584 7,057 36,150 82,151
1501 – 2000 gr 21 8,835 7,164 3,470 24,090 43,559
2001 – 2500 gr 15 463 3,181 1,107 7,440 12,191
≥2500 grs 29 2,798 5,588 2,290 12,140 22,816
deaths 7 3,531 2,455 597 1,560 8,143
Gestational Age
< 24 weeks 0 - - - - -
24 ≤ weeks < 28 8 11,146 7,730 3,722 17,560 40,158
28 ≤ weeks < 32 18 34,088 11,544 4,934 27,810 78,377
≥32 weeks 66 15,446 16,673 8,833 46,430 87,382
Deaths 7 3,531 2,455 597 1,560 8,143
All Infants 99 64,211 38,402 18,087 93,360 214,060
Table 2: Characteristics of the Sample (n = 99)
Infants' Characteristics In absolute numbers (%)
ELENA 
VENIZELOU 
HOSPITAL
ALEXANDRA 
HOSPITAL
No. of patients 44 (44.4) 55 (55.5)
Male 28 (63.6) 30 (54.5)
Female 16 (36.4) 25 (45.5)
Place of residence
Urban Areas 35 (79.5) 35 (63.6)
Rural Area 9 (20.5) 20 (36.4)
Mother's Age* 30.6 ± 5.1 29.44 ± 6.5
Mother's Insurance coverage 41 (93.2) 42 (76.4)
Mean Gestational Age* (wks) 35.1 ± 3.9 32.1 ± 5.06
Mean Weight (grs)* 2327 ± 787.8 1665 ± 846.4
Weight Classification (n)
< 1000 gr - 9 (16.4)
1001 – 1500 gr 5 (11.4) 13 (23.6)
1501 – 2000 gr 7 (15.9) 14 (25.4)
2001 – 2500 gr 9 (20.4) 6 (10.9)
≥2500 grs 20 (45.4) 9 (16.4)
Gestational Age (n)
< 24 weeks - -
24 ≤ wks < 28 2 (4.5) 6 (10.9)
28 ≤ wks < 32 3 (6.8) 15 (27.3)
≥32 wks 36 (81.8) 30 (54.5)
Deaths 3 (6.8) 4 (7.3)
Mean LOS in NICU 9.8 ± 15.5 18.4 ± 17.4
Mean LOS in Section II 8.9 ± 8.3 16.1 ± 13.2
Mean Length of Stay (LOS) 18.7 34.5
* Mean ± Standard DeviationCost Effectiveness and Resource Allocation 2007, 5:9 http://www.resource-allocation.com/content/5/1/9
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In order to reflect better the cost of the selected neonates
the median cost per infant was also used. It was estimated
at €4.927 (Q1: 4,371; Q3: 6,604; IQ: 2,232), showing a
difference of €918 from the mean.
Discussion
The present cost assessment was arisen from the insuffi-
cient coverage of beds in the intensive care units in general
and in particular for neonates, of the public hospitals in
the country. The continuously rising demands for NICUs
in the big urban centers, the lack of ICU beds and the une-
qual geographical distribution of public NICUs has
recently lead the government to contract intensive care
services from the private sector. Although the adoption of
such a policy is thought to bring about positive results, so
far its outcomes have not been evaluated.
The current study had as primary objective to estimate the
cost of neonatal intensive care unit. The estimation of the
hospitalization cost of neonates in comparison to the
amount reimbursed from the social security funds could
lead to a successful synergy between the public and private
healthcare sector, to the reduction of public hospitals' def-
icits and to empower coverage of social security funds
with the private hospitals.
According to the results of the study, the mean cost per
infant hospitalized in a NICU in the two major public
maternity hospitals in Athens, was estimated at €5.845,
when the social security funds reimbursed €3.952 for
every neonate admitted. This finding is important since it
depicts the factors responsible for a potential failure of
this public-private mix in the provision of intensive care
for neonates. Private hospitals may not be willing to
accept reimbursement according to the infants' nominal
cost (€ 3.952). Reimbursement should be adjusted to
make neonatal intensive care economically viable to pri-
vate hospitals and thereby increase capacity of the service
overall.
It is believed that the importance of carrying out such a
study was threefold: firstly, because it relates to the analyt-
ical identification of cost drivers and the assessment of
resource consumption per infant in a NICU in Greece.
Secondly, it involved the estimation of hospitalisation
costs according to patients' classification. Similar studies
in Greece are not often encountered in the literature due
to the lack of specialty unit prices based on diagnostic or
clinical performance criteria [6,24]. Thirdly, because it
becomes evident that cost analysis allows the possibility
of introducing diagnostic related patients' grouping and
abandoning the per diem payment, which results in enor-
mous deficits in the public hospitals' budgets [15-17]. It is
Table 5: Cost breakdown per infant hospitalized in NICU 
(*rounded to the closest integer)
Cost components Mean Cost per 
infant* in €
Cost 
distribution in %
Laboratory-diagnostic tests 388 6.64
Pharmaceutical expenses 649 11.1
Enteral/Parenteral costs 943 16.1
Consumables 183 3.1
Personnel Cost 3.499 59.9
Overhead Cost 183 3.1
Total cost 5.845 100
Table 4: Mean cost per infant in Athens in 2004 Euros (rounded to the closest integer)
Infants 
Classification
NL e n g t h  o f  
Stay (LOS)
Ancillary 
Cost (€)
Overhead 
Cost (€)
Cost of 
Personnel (€)
Total 
Cost (€)
Cost per 
Infant (€)
Amount 
Reimbursed (€)
Birth Weight
< 1000 gr 9 33.89 45,199 1,651 31,491 78,341 8,705 8,149
1001 – 1500 gr 18 34.50 82,151 3,302 62,981 148,434 8,246 8,441
1501 – 2000 gr 21 12.95 43,559 3,852 73,478 120,889 5,757 4,369
2001 – 2500 gr 15 5.3 12,191 2,751 52,484 67,427 4,495 1,941
≥2500 grs 29 5.0 22,818 5,319 101,470 129,607 4,469 1,380
deaths 7 3.9 8,143 1,284 24,493 33,919 4,846 724
Gestational Age
< 24 weeks 0 - - - - - -
24 ≤ weeks < 28 8 55.9 40,158 1,467 27,992 69,617 8,702 8,757
28 ≤ weeks < 32 18 49.1 78,377 3,302 62,981 144,660 8,037 7,158
≥32 weeks 66 30.6 87,382 12,106 230,931 330,420 5,066 2,837
Deaths 7 3.9 8,143 1,284 24,493 33,919 4,846 724
All Infants 99 27.5 214,060 18,159 346,397 578,616 5,845* 3,952
* including deaths as wellCost Effectiveness and Resource Allocation 2007, 5:9 http://www.resource-allocation.com/content/5/1/9
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believed that the classification of infants, per birth weight
or gestational age, could easily constitute diagnostic
related patients' categories combined with a prospective
hospital payment system. In that case, it is apparent that
private health care providers would have some economic
motivation in profiting through the public-private mix
expansion in the country.
In an effort to compare our results to those of the interna-
tional literature in cost analysis of NICUs, differences and
similarities have been observed. Differences can be
explained by the availability of economic data, the choice
between private or public health care sector unit prices
and the variability of the accounting methods for measur-
ing the economic costs. According to an extensive litera-
ture review performed by Petrou [13] the mean cost per
infant category of 1001–1500 gr, was $45,152 for studies
conducted in the US and $19,975 for the non US studies
(in 2004 USD). A study conducted by the Washington
Office of Technology Assessment [8] estimated the mean
cost per infant weighting 1501–2000 gr to be $10,948 and
for those with birthweight over 2500 gr at $1,531. In the
present study the mean cost per infant hospitalised in a
public NICU was estimated at $10,438 for infants weight-
ing 1001–1500 gr, while for those exceeding 2500 gr
reached $5,657.
Furthermore, as reported earlier, it was found that infants'
hospitalisation cost varies inversely with birth weight,
since it reflects differences in both the mean length of stay
and in the intensity of treatment during each day of stay
[7,13,19,25]. In addition, the high share of the personnel,
parenteral feeding and pharmaceutical care costs is an evi-
dent found in most cost analysis studies both in Greece
and abroad [25-27].
At this point some methodological limitations should be
mentioned. The mean cost per infant is underestimated
primarily due to the use of NHS prices, which are far lower
than those of the private maternity hospitals. The lack of
data and the non-responsiveness of the private sector to
provide the necessary information did not allow us to esti-
mate the latter. Secondarily, due to the fact that the official
registration of public hospitals' expenses did not include
costs for depreciation of capital assets, so they were
excluded from our microeconomic analysis.
To avoid overestimation of cost per infant in categories
with small sample size, groups were collapsed to provide
more reliable results. Additionally, sensitivity analysis
increased the reliability of the results, since it showed that
mean cost per infant were similar when excluding outliers
(€5,845 vs. €5,742), despite the fact that the difference
was found statistically significant.
Conclusion
Through the analysis of this study it becomes evident that
the identification of cost per infant can facilitate public-
private contracts to expand access to neonatal intensive
care, once the significant underpayment by the social fund
is adjusted. It seems most important at this time period
when a public – private mix effort is under consideration
and hospital budgets become more restrained. For all the
above-mentioned reasons, economic assessment is neces-
sary in Greece since it will facilitate policy makers in their
decision making.
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Appendix 1 – Unit Costs of consumables. The data provided represent the 
unit costs and resource consumption of the consumables used during 
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Appendix 2 – Unit Costs of laboratory tests. The data provided represent 
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